John M. Grange - Concepedia

Author

John M. Grange

Also Known As

I.M. Grange, J .M GRANGE, J Grange, J Grangé, J M Grange, J. Grange, J. M GRANGE;, J. M Grange, J. M. GRANGE, J. M. Grange

283

Publications

9.1K

Citations

H-Index

139

Concepts

All Affiliations

University College London Royal Brompton Hospital Dulwich Community Hospital The Royal Free Hospital University of Göttingen

About

John M. Grange is an author at University College London specializing in medicine, tuberculosis, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	65	2.7K
2	Public Health	11	11	605
3	Health Sciences	3	3	127
4	Engineering	1	1	28
5	Natural Sciences	1	1	28

John M. Grange

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
The global emergency of tuberculosis: what is the cause? John M. Grange, Alimuddin Zumla The Journal of the Royal Society for the Promotion of Health Tuberculosis PreventionGlobal EmergencyDrug ResistancePreventive MedicineEffective Control	2002	141
The meaning and structure of species as applied to mycobacteria J.L. Stanford, John M. Grange Tubercle BiologyMicrobial DiversityMicrobial SystematicsPathogenic MicrobiologyBacteriology	1974	137
A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. Yusuf Ahmed, Peter Mwaba, Chifumbe Chintu, PubMed	1999	126
Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro John M. Grange, Noel Snell Journal of Ethnopharmacology Medicinal ChemistryPulmonary TuberculosisMedicineMycobacterium TuberculosisTuberculosis	1996	119
T4 lymphopenia in patients with active pulmonary tuberculosis. John S. Beck, R C Potts, T. Kardjito, PubMed T-regulatory CellTuberculosis PreventionImmunologyPathologyImmunotherapy	1985	91
Protection against melanoma by vaccination with Bacille Calmette-Guérin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control Bernd Krone, Klaus F. Kölmel, Beate M. Henz, European Journal of Cancer VaccinationVaccine SafetyVaccinologyMelanomaImmunology	2004	89
Inverse Association Between Melanoma and Previous Vaccinations Against Tuberculosis and Smallpox: Results of the FEBIM Study Annette Pfahlberg, Daniela Schneider, Wolfgang Uter, Journal of Investigative Dermatology VaccinologyVaccinationVaccine TargetMelanomaImmunology	2002	85
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients K.F. Kölmel, John M. Grange, Bernd Krone, European Journal of Cancer VaccinationCancer Cohort StudyCancer ImmunosurveillanceMedicineMelanoma	2004	82
Impact of vaccinations and infectious diseases on the risk of melanoma—evaluation of an EORTC case–control study Bernd Krone, K.F. Kölmel, John M. Grange, European Journal of Cancer VaccinationVaccine SafetyPreventive MedicineCancer EpidemiologyMelanoma	2003	74
The production and preliminary investigation of Burulin, a new skin test reagent for <i>Mycobacterium ulcerans</i> infection J. L. Stanford, W. D. L. Revill, W. J. Gunthorpe, Journal of Hygiene	1975	74

Page 1